- Release Date: 31/01/17 08:22
- Summary: Quarterly Cashflow Report
- Price Sensitive: Yes
- Download Document 277.45KB
- Forums
- ASX - By Stock
- AEV
- Ann: Quarterly Cashflow Report
Ann: Quarterly Cashflow Report
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $29.74M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $7.4K | 720.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 5987559 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1555190 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 5987559 | 0.010 |
6 | 2526000 | 0.009 |
5 | 1504999 | 0.008 |
3 | 1400000 | 0.007 |
5 | 10755000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1555190 | 3 |
0.012 | 2047093 | 7 |
0.013 | 5200066 | 8 |
0.014 | 599999 | 1 |
0.015 | 2790146 | 6 |
Last trade - 15.31pm 10/10/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online